Sale

Scar Treatment Market

Global Scar Treatment Market Size, Trends, Growth, Analysis: By Product Type: Topical Products, Laser Products, Injectables, Others; By Scar Type: Atrophic Scars, Hypertrophic Scars, Contracture Scars, Stretch Marks, Others; By End User: Hospitals, Clinics, Others; By Distribution Channels; Regional Analysis; Supplier Landscape; 2024-2032

Global Scar Treatment Market Outlook

The global scar treatment market value was USD 21.51 billion in 2023, driven by the prevalence of skin conditions, and rising awareness about the availability of scar treatment options across the globe. The market size is anticipated to grow at a CAGR of 10.9% during the forecast period of 2024-2032 to achieve a value of USD 54.59 billion by 2032.

 

Scar Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Segmentation

The global scar treatment market can be segmented based on:

 

Scar Treatment Market By Segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Scar Type 
    • Atrophic Scars
    • Hypertrophic and Keloid Scars
    • Contracture Scars
    • Stretch Marks
    • Others 
  • Product Type
    • Topical Products
      • Creams
      • Gels
      • Oils
      • Other Topical Product
    • Laser Product
      • CO2 Laser
      • Pulse-dyed Laser
      • Other Laser Products
    • Injectable Product
    • Others
  • End Use
    • Hospitals/Clinics
    • Retail Drug Stores
    • E-commerce Stores

The EMR report looks into the regional scar treatment markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Market Analysis

The global scar treatment market is being driven by the increasing demand for scar removal treatment for burn injuries caused by the rising cases of road accidents. The global market is further driven by the introduction of laser therapy that helps in destroying scar tissue. The hospital segment is the largest shareholder in the market because products such as topical creams and gels, laser instruments, and steroid injections are commonly used for scar removal in hospitals. North America is the leading regional market as a result of the high penetration of laser-based products in skin restoration and scar treatment, instant adoption of advanced products, and the growing awareness regarding aesthetic appearance.

 

Scar Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global scar treatment market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Alliance Pharma PLC
  • Bausch Health Companies Inc. (Solta Medical)
  • Smith & Nephew plc
  • Laboratoire HRA Pharma SAS
  • Lumenis Ltd.
  • Sonoma Pharmaceuticals, Inc.
  • Cynosure LLC
  • Sientra, Inc.
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s five forces.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Scar Type
  • End User
  • Distribution Channels
  • Region
Breakup by Product Type
  • Topical Products
  • Laser Products
  • Injectables
  • Others
Breakup by Scar Type
  • Atrophic Scars
  • Hypertrophic Scars
  • Contracture Scars
  • Stretch Marks
  • Others
Breakup by End User
  • Hospitals
  • Clinics
  • Homecare
  • Specialty Centers
  • Others
Breakup by Distribution Channels
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Smith Nephew
  • Merz Pharma
  • Lumenis
  • Perrigo Company plc
  • Mölnlycke Health Care AB
  • CCA Industries, Inc.
  • Newmedical Technology Inc
  • Suneva Medical
  • Stratpharma AG
  • OLIX PHARMACEUTICALS, INC.
  • Geomedics Pharma
  • Vicore Pharma
  • Nidus Pharma Pvt. Ltd.
  • Sientra, Inc.
  • RXi Pharmaceuticals
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Sanofi
  • Bausch Health
  • Bayer AG

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Scar Treatment Overview

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Scar Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Scar Epidemiology (2016-2031)
    5.3    Europe Scar Epidemiology (2016-2031)
    5.4    Asia-Pacific Scar Epidemiology (2016-2031)
    5.5    Latin America Scar Epidemiology (2016-2031)
    5.6    Middle East & Africa Scar Epidemiology (2016-2031)
6    Global Scar Treatment Market Overview
    6.1    Global Scar Treatment Market Historical Value (2017-2023) 
    6.2    Global Scar Treatment Market Forecast Value (2024-2032)
7    Global Scar Treatment Market Landscape
    7.1    Global Scar Treatment Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Global Scar Treatment Product Landscape
        7.2.1    Analysis by Product Type
        7.2.2    Analysis by End User
        7.2.3    Analysis by Distribution Channel
8    Scar Treatment Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Scar Treatment Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model 
    10.4    Key Demand Indicators
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends 
    10.7    Value Chain Analysis
11    Global Scar Treatment Market Segmentation
    11.1    Global Scar Treatment Market, by Product Type
        11.1.1    Market Overview
        11.1.2    Topical Products
            11.1.2.1    Creams
            11.1.2.2    Gels
            11.1.2.3    Silicon Sheets
            11.1.2.4    Other Topical Products
        11.1.3    Laser Products
            11.1.3.1    CO2 Laser
            11.1.3.2    Pulse-dyed Laser
            11.1.3.3    Other Laser Products
        11.1.4     Injectables
        11.1.5    Others
    11.2    Global Scar Treatment Market, by Scar Type
        11.2.1    Market Overview
        11.2.2    Atrophic Scars
        11.2.3    Hypertrophic Scars
        11.2.4    Contracture Scars
        11.2.5    Stretch Marks
        11.2.6    Others
    11.3    Global Scar Treatment Market, by End User
        11.3.1    Market Overview
        11.3.2    Hospitals
        11.3.3    Clinics
        11.3.4    Homecare
        11.3.5    Specialty Centers
        11.3.6    Others
    11.4    Global Scar Treatment Market, by Distribution Channels
        11.4.1    Market Overview
        11.4.2    Hospitals Pharmacies
        11.4.3    Retail Pharmacies
        11.4.4    Online Pharmacies
        11.4.5    Others
    11.5    Global Scar Treatment Market by Region
        11.5.1    Market Overview
        11.5.2    North America 
        11.5.3    Europe
        11.5.4    Asia Pacific
        11.5.5    Latin America
        11.5.6    Middle East and Africa
12    North America Scar Treatment Therapy Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Scar Treatment Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Scar Treatment Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Scar Treatment Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Scar Treatment Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Patent Analysis
    17.1    Analysis by Type of Patent
    17.2    Analysis by Publication year
    17.3    Analysis by Issuing Authority
    17.4    Analysis by Patent Age
    17.5    Analysis by CPC Analysis
    17.6    Analysis by Patent Valuation 
    17.7    Analysis by Key Players
18    Grants Analysis
    18.1    Analysis by year
    18.2    Analysis by Amount Awarded
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Grant Application
    18.5    Analysis by Funding Institute
    18.6    Analysis by NIH Departments
    18.7    Analysis by Recipient Organization 
19    Clinical Trials Analysis 
    19.1     Analysis by Trial Registration Year 
    19.2    Analysis by Trial Status 
    19.3    Analysis by Trial Phase 
    19.4    Analysis by Therapeutic Area 
    19.5    Analysis by Geography 
20    Funding Analysis
    20.1    Analysis by Funding Instances
    20.2    Analysis by Type of Funding
    20.3    Analysis by Funding Amount
    20.4    Analysis by Leading Players
    20.5    Analysis by Leading Investors
    20.6    Analysis by Geography
21    Partnership and Collaborations Analysis
    21.1    Analysis by Partnership Instances
    21.2    Analysis by Type of Partnership
    21.3    Analysis by Leading Players
    21.4    Analysis by Geography
22    Regulatory Framework
    22.1    Regulatory Overview
        22.1.1    US FDA
        22.1.2    EU EMA
        22.1.3    INDIA CDSCO
        22.1.4    JAPAN PMDA
        22.1.5    Others
23    Supplier Landscape
    23.1    Smith Nephew
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    Merz Pharma
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Lumenis
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Perrigo Company plc
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    Mölnlycke Health Care AB
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    CCA Industries, Inc.
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    Newmedical Technology Inc
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Suneva Medical
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    Stratpharma AG
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    OLIX PHARMACEUTICALS, INC.
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
    23.11    Geomedics Pharma
        23.11.1    Financial Analysis
        23.11.2    Product Portfolio
        23.11.3    Demographic Reach and Achievements
        23.11.4    Mergers and Acquisitions
        23.11.5    Certifications
    23.12    Vicore Pharma
        23.12.1    Financial Analysis
        23.12.2    Product Portfolio
        23.12.3    Demographic Reach and Achievements
        23.12.4    Mergers and Acquisitions
        23.12.5    Certifications
    23.13    Nidus Pharma Pvt. Ltd.
        23.13.1    Financial Analysis
        23.13.2    Product Portfolio
        23.13.3    Demographic Reach and Achievements
        23.13.4    Mergers and Acquisitions
        23.13.5    Certifications
    23.14    Sientra, Inc.
        23.14.1    Financial Analysis
        23.14.2    Product Portfolio
        23.14.3    Demographic Reach and Achievements
        23.14.4    Mergers and Acquisitions
        23.14.5    Certifications
    23.15    RXi Pharmaceuticals
        23.15.1    Financial Analysis
        23.15.2    Product Portfolio
        23.15.3    Demographic Reach and Achievements
        23.15.4    Mergers and Acquisitions
        23.15.5    Certifications
    23.16    Johnson & Johnson Services, Inc.
        23.16.1    Financial Analysis
        23.16.2    Product Portfolio
        23.16.3    Demographic Reach and Achievements
        23.16.4    Mergers and Acquisitions
        23.16.5    Certifications
    23.17    Novartis AG
        23.17.1    Financial Analysis
        23.17.2    Product Portfolio
        23.17.3    Demographic Reach and Achievements
        23.17.4    Mergers and Acquisitions
        23.17.5    Certifications
    23.18    Sanofi
        23.18.1    Financial Analysis
        23.18.2    Product Portfolio
        23.18.3    Demographic Reach and Achievements
        23.18.4    Mergers and Acquisitions
        23.18.5    Certifications
    23.19    Bausch Health
        23.19.1    Financial Analysis
        23.19.2    Product Portfolio
        23.19.3    Demographic Reach and Achievements
        23.19.4    Mergers and Acquisitions
        23.19.5    Certifications
    23.20    Bayer AG
        23.20.1    Financial Analysis
        23.20.2    Product Portfolio
        23.20.3    Demographic Reach and Achievements
        23.20.4    Mergers and Acquisitions
        23.20.5    Certifications
24    Global Scar Treatment Market- Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies 
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The scar treatment market was valued at USD 21.51 billion in 2023.

The market is expected to grow at a CAGR of 10.9% from 2024 to 2032 to reach a value of USD 54.59 billion by 2032.

The major drivers of the market include the growing concern amongst people regarding their aesthetic appeal, growing introduction of laser therapy, rising adoption of advanced products, and development of advanced healthcare infrastructures.

The increasing demand for scar removal treatment for burn injuries caused by the rising cases of road accidents is the key industry trend propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading scar type segments in the market are atrophic scars, hypertrophic and keloid scars, contracture scars, and stretch marks, among others.

The significant product types in the industry are topical products, laser product, and injectable product, among others.

The major end users of scar treatment in the market are hospitals/clinics, retail drug stores, and e-commerce stores.

The major players in the industry are Alliance Pharma PLC, Bausch Health Companies Inc. (Solta Medical), Smith & Nephew plc, Laboratoire HRA Pharma SAS, Lumenis Ltd., Sonoma Pharmaceuticals, Inc., Cynosure LLC, Sientra, Inc., Others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER